How Smarteeva’s Analysis of FDA Data Shows Patient Death Codes Declining as a Percentage of MDRs

What the Patient Death Code Actually Means

The Patient Death code is one of many Health Effect codes FDA uses to classify MDRs. When a manufacturer files an MDR with this code, it means the patient died during the period the device was in use. It does not establish causation. The device may or may not have contributed to the death. The code is a classification marker, not a liability finding.

This distinction matters because the raw numbers are often misread. A high count of Patient Death codes does not mean a device is dangerous. It may mean the device is used in high-acuity clinical settings where patient mortality is inherent to the condition being treated.

What the Data Shows: A Declining Percentage

Smarteeva’s analysis of FDA MAUDE data reveals a clear downward trend: patient death codes are declining as a percentage of total MDRs filed. The absolute number of MDRs is rising, driven by expanded reporting requirements and higher device utilization. But the share classified with a Patient Death code is shrinking.

Several factors explain this trend. Device design has improved. Clinical monitoring is more proactive. Complaint response times have shortened, meaning adverse events are caught and addressed earlier. And the FDA’s expansion of mandatory reporting has broadened the types of events that generate MDRs, increasing the denominator without a proportional increase in death-coded reports.

Why This Analysis Matters for Manufacturers

For medical device companies, understanding these trends is operational intelligence. If your device category shows a different pattern from the industry average, that is a signal worth investigating. If your Patient Death percentage is rising while the industry trend is falling, it may indicate a product-specific issue that warrants deeper analysis.

Smarteeva’s MDREngine makes this analysis possible at scale. Cross-reference your internal complaint data against FDA MAUDE trends by device type, manufacturer, time period, and event code. The data exists. The question is whether your system can surface the patterns.

2.6M+ global safety records in MDREngine for benchmarking

35% of all FDA MDRs filed through Smarteeva

Closing

Patient death codes declining as a percentage of MDRs is a positive signal for the industry. But the analysis only matters if manufacturers are tracking it. Smarteeva’s MDREngine gives quality and regulatory teams the tools to monitor these trends against their own complaint data, by device, by market, and by time period.

‍